TNPO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.21014309684142E-14 |
Normal-vs-Stage2 |
3.9043999999766E-07 |
Normal-vs-Stage3 |
1.73194791841524E-14 |
Normal-vs-Stage4 |
2.96240809660731E-12 |
Stage1-vs-Stage2 |
9.255000E-01 |
Stage1-vs-Stage3 |
8.903700E-02 |
Stage1-vs-Stage4 |
1.713440E-01 |
Stage2-vs-Stage3 |
2.540000E-01 |
Stage2-vs-Stage4 |
3.314600E-01 |
Stage3-vs-Stage4 |
9.188800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62503344114384E-12 |
Normal-vs-AfricanAmerican |
1.63447033685316E-12 |
Normal-vs-Asian |
5.018500E-02 |
Caucasian-vs-AfricanAmerican |
5.049600E-02 |
Caucasian-vs-Asian |
2.636600E-01 |
AfricanAmerican-vs-Asian |
4.384500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.70852221259565E-12 |
Male-vs-Female |
6.803600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.77469999701674E-09 |
Normal-vs-Age(41-60Yrs) |
1.64535052249448E-12 |
Normal-vs-Age(61-80Yrs) |
1.62525548574877E-12 |
Normal-vs-Age(81-100Yrs) |
1.22790000389728E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.863600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.474200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.165400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.182400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.059400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.413200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.396900E-04 |
Normal-vs-Grade 2 |
1.91791027503996E-12 |
Normal-vs-Grade 3 |
1.62536650805123E-12 |
Normal-vs-Grade 4 |
1.62747593179802E-12 |
Grade 1-vs-Grade 2 |
8.743600E-01 |
Grade 1-vs-Grade 3 |
4.726200E-01 |
Grade 1-vs-Grade 4 |
1.959200E-01 |
Grade 2-vs-Grade 3 |
1.277560E-01 |
Grade 2-vs-Grade 4 |
3.060400E-02 |
Grade 3-vs-Grade 4 |
2.746400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.27859961402055E-10 |
Normal-vs-ccB subtype |
1.6654455592402E-12 |
ccA subtype-vs-ccB subtype |
6.230200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.67543756646182E-12 |
Normal-vs-N1 |
1.357150E-04 |
N0-vs-N1 |
9.957800E-01 |
|
|